Related Experiment Videos
[Effect of matrix metalloproteinase inhibitor on experimental pseudomonal corneal ulceration]
K Kosaku1, N Maeda, T Yokoyama
1Department of Ophthalmology, Nihon University School of Medicine, Tokyo, Japan.
Abstract:
We examined the effect of matrix metalloproteinase (MMP) inhibitor (CS-610) on experimental pseudomonal corneal ulceration by clinical and histological evaluation. Intrastromal injection of 3.5 microliters sterile culture broth of P. aeruginosa, IID-1117 (13.5 unit Type I collagenase equivalent proteinase activities), was done to induce corneal ulcers in guinea pigs. The animals were divided into two groups of 23 each. The CS-610 group received topical CS-610 (400 micrograms/ml) treatment at 2-hour intervals and the control group received only the vehicle of CS-610 at the same intervals. In the control group, corneas developed acute corneal damage following corneal ulcerations at 6-12 hours. In the CS-610 group, these corneal lesions were inhibited in most of the eyes (p < 0.01). In the late period, as inflammatory cells migrated into the cornea, some animals of the CS-610 group developed corneal ulcer. The results indicated that CS-610 had a potent inhibitory activity against pseudomonal proteinases in vivo. The results also suggested that the mechanism of the ulceration model involved not only pseudomonal proteinases but also endogenous responses.
Insights
Matrix metalloproteinase (MMP) inhibitor CS-610 effectively reduced experimental pseudomonal corneal ulceration in guinea pigs. This study highlights CS-610
Area of Science:
- Ophthalmology
- Microbiology
- Pharmacology